According to two sources who have seen the lab results, China’s CoronaVac, its COVID-19 vaccine, developed by Sinovac Biotech, has a general efficacy of less than 60% in clinical trial in Brazil. Brazil’s Sao Paulo’s Butantan biomedical center, which has… Read More ›